HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Ranitidine Hydrochloride

HCID 3033332
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
66357-59-3
Standard SMILES
CN/C(=C\[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1.Cl
InChIKey
GGWBHVILAJZWKJ-KJEVSKRMSA-N
Molecular formula
C13H23ClN4O3S
Average molar mass
350.87 g/mol
Monoisotopic mass
350.1179395

Overview

Ranitidine Hydrochloride is a member of the class of histamine H2-receptor antagonists with antacid activity. Ranitidine is a competitive and reversible inhibitor of the action of histamine, released by enterochromaffin-like (ECL) cells, at the histamine H2-receptors on parietal cells in the stomach, thereby inhibiting the normal and meal-stimulated secretion of stomach acid. In addition, other substances that promote acid secretion have a reduced effect on parietal cells when the H2 receptors are blocked.

Names & identifiers

Preferred name
Ranitidine Hydrochloride
IUPAC
(E)-1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine;hydrochloride
English name
Ranitidine Hydrochloride
Molecular formula
C13H22N4O3S.ClH
Molecular weight
350.87

Names & synonyms

ranitidine hydrochloride66357-59-3Ranitidine HCLAzantacRaniblocNu-RanitRani-QFendibinaGastridinaGastrolavKuracidAlquen
Show more names
noctoneRanitidine HydrochloorideRANITIDINEHYDROCHLORIDE,USPRanitidine hydrochloride CRSZamecZANTACMelfaxZintacranidilah19065
Zantac In Plastic ContainerRani-nertonZANTAC 300RaniticWal-zan 75Ranitidine-Acid ReducerZantac 75Zantac 150

Database identifiers

CAS
66357-59-3、71130-06-8
PubChem CID
3033332
ChEMBL
CHEMBL2110372
EC Number
266-333-0、275-207-4

Properties

Computed structural properties

Topological polar surface area
112 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
7
Rotatable bonds
9
Heavy atoms
22
Formal charge
0
Complexity
347

Experimental & physicochemical properties

Chemical ClassesOther Uses -> Pharmaceuticals
Human Drugs · 3 items

Breast Feeding; Lactation; Milk, Human; Anti-Ulcer Agents; Histamine H2 Antagonists; Gastrointestinal Agents

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physicochemical properties

Melting point
134 °C · 134°C (dec.)
storage temp.
2 · 2-8°C
solubility
2 O: · H2O: 1.8 mg/mL
form
solid
pka
8.27 · 8.27 (pKa2)
color
tan
Water Solubility
2 · Soluble in water, 2-hydroxypropyl-beta-cyclodextrin, acetic acid, methanol, ethanol and dimethyl sulfoxide. Insoluble in chloroform.
Sensitive
Hygroscopic
Merck
14 · 14,8110
BCS Class
3 · 3/1
Stability
Hygroscopic

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 6 items

This chemical does not meet GHS hazard criteria for 3.9% (3 of 76) of reports.

Danger

H315 (85.5%): Causes skin irritation [Warning Skin corrosion/irritation]

P233, P260, P261, P264, P264+P265, P271, P272, P280, P284, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 76 reports by companies from 14 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

Hazard information

Regulatory InformationRanitidine hydrochloride: Does not have an individual approval but may be used under an appropriate group standard
Hazards Summary · 1 item

Allergic contact dermatitis reported in pharmaceutical workers; [Kanerva, p. 1170] Ranitidine is a drug to reduce acid secretion in the stomach. Many side effects have been reported after ingestion of therapeutic doses including, rarely, drug-induced hepatitis. [HSDB]

Hazard Classes and Categories · 2 items

Skin Irrit. 2 (100%)

Skin Irrit. 2 (85.5%)

Toxicology

Adverse EffectsOccupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation.
Drug Induced Liver Injury · 6 items

Chemistry & industry

Pharmacology

FDA Pharmacological Classification · 2 items

RANITIDINE HYDROCHLORIDE

Histamine-2 Receptor Antagonist [EPC]; Histamine H2 Receptor Antagonists [MoA]

MeSH Pharmacological Classification · 2 items

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.

Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood.

Uses & manufacturing

UsesUse (kg) in Switzerland (2009): >1000
Applications · 3 items

UsesA histamine H2-receptor antagonist which inhibits gastric acid secretion. Antiulcerative.

Usesantifungal

UsesAn H-2 histamine receptor antagonistRanitidine hydrochloride is mainly used as an H2-receptor antagonist and helps in the treatment of gastrointestinal lesions because of excessive gastric acid secretion. It also serves as an antiulcer drug.

Related reactions

5 records
New reaction record
HRID 279493 reaction equation
HRID 279493As reactantuspto-grants-2002_03
HRID 397176 reaction equation
HRID 397176As reactantuspto-grants-2003_08
HRID 1079382 reaction equation
HRID 1079382As reactantuspto-grants-1996_12
HRID 1596732 reaction equation
HRID 1596732As reactantuspto-grants-2001_09
HRID 1957572 reaction equation
HRID 1957572As reactantuspto-grants-1998_07

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
Major Application
pharmaceutical (small molecule)
InChI
InChI=1S/C13H22N4O3S.ClH/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;/h4-5,9,14-15H,6-8,10H2,1-3H3;1H/b13-9+;
InChIKey
GGWBHVILAJZWKJ-KJEVSKRMSA-N
SMILES
C(/NC)(\NCCSCC1OC(CN(C)C)=CC=1)=C/[N+]([O-])=O.[H]Cl
CAS DataBase Reference
66357 · 66357-59-3(CAS DataBase Reference)
FDA UNII
76465 IHM · BK76465IHM
NCI Drug Dictionary
Zantac
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07,GHS08
Signal word
Danger
Hazard statements
315 · H315-H317-H319-H334-H335
Precautionary statements
261 · P261-P264-P271-P280-P302+P352-P305+P351+P338
target organs
Respiratory system
Hazard Codes
F,T
Risk Statements
20 · 20/21/22-39/23/24/25-23/24/25-11
Safety Statements
22 · 22-24/25-45-36/37-16-7
WGK Germany
2 · 2
RTECS
6557000 · KM6557000
HS Code
2932190002 · 2932190002
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
2 Resp · Eye Irrit. 2Resp. Sens. 1Skin Irrit. 2Skin Sens. 1STOT SE 3

Drug Induced Liver Injury Rank (DILIrank 2.0)

Ranitidine hydrochloride

vLess-DILI-concern

5

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Safety data

wgk
2
rtecs
KM6557000
hs_code
2932190002
risk_code
20/21/22-39/23/24/25-23/24/25-11
Signal word
Danger
Symbol(GHS)
GHS07,GHS08
hazard_code
F,T
safety_code
22-24/25-45-36/37-16-7
Storage Class
11 - Combustible Solids
target organs
Respiratory system
Hazard statements
H315-H317-H319-H334-H335
Hazard Classifications
Eye Irrit. 2Resp. Sens. 1Skin Irrit. 2Skin Sens. 1STOT SE 3
Precautionary statements
P261-P264-P271-P280-P302+P352-P305+P351+P338